We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies. Close

Intellectual Property Magazine RSS feed

Decision time

In the first of a two-partseries, David V Sanker discusses patentsversus trade secrets in the era of artificial intelligence

The home office

As the Covid-19 pandemic crisis deepens, Charles F Hauff Jr and R Lee Fraley explore the impact on IP ownership as more people switch to remote working

Weak link

John MMulcahy and Yanbin Xu consider the difficulties in procuringand enforcing patents on blockchain technologies

Altered states

Rebecca Anderson-Smith and Joe McAlary consider what happens whentrademarks are altered in reaction to Covid-19

Rise of pharmaceutical nationalism?

Queen Mary Intellectual Property Research Institute’s Duncan Matthews asks whether the US stance on tackling Covid-19 is enlightened independence or the sign of a new protectionist era?

Ethical framework

Jean-David Behlow explores the data protection considerations triggered by the use of AI

Drawing the line

Tolga S Gulmen explores the issues around establishing clarity on patent protection and diagnostic methods in the US

Unauthorised disclosure

As more people work remotely, businesses should enhance their protection of confidential information say Houlihan’s Elizabeth Houlihan and Victoria Longshaw

A cure for Covid-19 – patent pending?

Intellectual Property Office of Singapore’s patent examiners Chen Xiuli, Du Ning and Terence Tan Tze Tong discuss how stimulating innovation now is critical not only to resolve the current pandemic, but also to prepare for future public health emergencies

Welcome clarity

Mewburn Ellis’ Rhiannon Wescott outlines whether or not a functionally defined patent claim can protect medicinal products